A Study to Develop Predictive and Prognostic Tools for Optimizing Therapy With Bevacizumab Frontline Cancer Therapy in Participants With HER 2-Negative Aggressive Metastatic Breast Cancer
Clinical trial NCT02613208 · COMPLETED
Trial details
- NCT number
- NCT02613208
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-12-09
- Primary completion
- 2018-12-03
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.